Literature DB >> 10625619

Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.

H Floyd1, J Ni, A L Cornish, Z Zeng, D Liu, K C Carter, J Steel, P R Crocker.   

Abstract

We describe the characterization of siglec-8, a novel sialic acid-binding immunoglobulin-like lectin that is expressed specifically by eosinophils. A full-length cDNA encoding siglec-8 was isolated from a human eosinophil cDNA library. Siglec-8 is predicted to contain three extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail of 47 amino acids. The siglec-8 gene mapped on chromosome 19q13.33-41, closely linked to genes encoding CD33 (siglec-3), siglec-5, siglec-6, and siglec-7. When siglec-8 was expressed on COS cells or as a recombinant protein fused to the Fc region of human IgG(1), it was able to mediate sialic acid-dependent binding to human erythrocytes and to soluble sialoglycoconjugates. Using specific monoclonal antibodies, siglec-8 could be detected only on eosinophils and hence appears to be the first example of an eosinophil-specific transmembrane receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625619     DOI: 10.1074/jbc.275.2.861

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

Authors:  J Munday; S Kerr; J Ni; A L Cornish; J Q Zhang; G Nicoll; H Floyd; M G Mattei; P Moore; D Liu; P R Crocker
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.

Authors:  Z Yu; M Maoui; L Wu; D Banville; S Shen
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 3.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

4.  Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.

Authors:  Sherry A Hudson; Harald Herrmann; Jian Du; Paul Cox; El-Bdaoui Haddad; Barbara Butler; Paul R Crocker; Steven J Ackerman; Peter Valent; Bruce S Bochner
Journal:  J Clin Immunol       Date:  2011-09-22       Impact factor: 8.317

5.  IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils.

Authors:  Ho Jeong Na; Sherry A Hudson; Bruce S Bochner
Journal:  Cytokine       Date:  2011-11-12       Impact factor: 3.861

6.  Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8.

Authors:  Ho Jeong Na; Robert G Hamilton; Amy D Klion; Bruce S Bochner
Journal:  J Immunol Methods       Date:  2012-06-06       Impact factor: 2.303

Review 7.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

8.  Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8.

Authors:  Johannes M Pröpster; Fan Yang; Said Rabbani; Beat Ernst; Frédéric H-T Allain; Mario Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-29       Impact factor: 11.205

Review 9.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

Review 10.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.